UPDATE: SVB Leerink On Vocera Price Target Raise: Firm Positive On Solid Beat Featuring 'Meaningful Win With Cleveland Clinic'; Sees Increased Visibility Into FY22 Growth Given New Wins Of Scale Driving Backlog With Limited Impact From Supply Pressures